Cancer stem cell drugs target K-ras signaling in a stemness context.
Najumudeen AK, Jaiswal A, Lectez B, Oetken-Lindholm C, Guzmán C, Siljamäki E, Posada IM, Lacey E, Aittokallio T, Abankwa D.
Najumudeen AK, et al. Among authors: lectez b.
Oncogene. 2016 Oct 6;35(40):5248-5262. doi: 10.1038/onc.2016.59. Epub 2016 Mar 14.
Oncogene. 2016.
PMID: 26973241
Free PMC article.